fda bans semaglutide compounded weight loss drugs this month Semaglutide FDA Approval vs Compounded

Drugs that will produce 15 percent body weight loss we did not have that before in the medical therapy of obesity. With additional, potentially more effective GLP-1 receptor agonists coming online in the future, were at the beginning of a promising new chapter of obesity therapeutics

Wellness Add-Ons for a Customized Experience Breathe easier and recharge your body with pure oxygen

Efficacy of Tirzepatide Dual GIP/GLP-1 Receptor Agonist in Patients With Idiopathic Intracranial Hypertension

Inhibitory effect of peptide Epitalon on colon carcinogenesis induced by 1,2-dimethylhydrazine in rats

McGuire DK, Marx N, Mulvagh SL, et al